Psychosocial Mobile App for Chronic Graft-Versus-Host Disease

Chronic Graft-Versus-Host Disease Clinical Trial

Official title: Randomized Controlled Trial of a Psychosocial Mobile Application (App) to Promote Coping for Patients With Chronic Graft-Versus-Host Disease (GVHD)

Status Recruiting

Clinical Trial Summary

The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life, symptom burden, psychological distress, and coping in patients living with chronic graft-versus host disease (GVHD)

Clinical Trial Description

Frequently patients living with chronic GVHD experience physical and emotional symptoms during the course of illness that impacts their quality of life. Patients also often report difficulty managing many of the tasks they need to do to manage their chronic GVHD. They also frequently have a lot of questions about chronic GVHD and the expected trajectory of this illness.

The purpose of this research study is to see whether a psychosocial mobile app called Horizons is effective at improving quality of life, symptom burden, and psychological distress in patients with chronic GVHD

• This study will randomly assign participants to either receiving Horizons plus usual care or usual care alone.

• Enrolled participants will be on the research study for up to sixteen weeks and it is expected that about 120 people will take part in this research study.

The Leukemia and Lymphoma Society is supporting this research by providing funding. ;

Related Conditions & MeSH terms

• Allogeneic Stem Cell Transplant
• Bronchiolitis Obliterans Syndrome
• Chronic Graft-Versus-Host Disease
• Graft vs Host Disease

• NCT number: NCT05690971
• Study type: Interventional
• Source: Massachusetts General Hospital
• Contact: Areej El-Jawahri, MD
• Phone: 617-643-4003
• Email: AEL-JAWAHRI@PARTNERS.ORG
• Status: Recruiting
• Phase: N/A
• Start date: January 23, 2023
• Completion date: April 1, 2025